Erythropoietic ProtoporphyriaSymptoms, Doctors, Treatments, Advances & More
Erythropoietic Protoporphyria Overview
Learn About Erythropoietic Protoporphyria
- Autosomal erythropoietic protoporphyria
- EPP
- Erythrohepatic protoporphyria
- Ferrochelatase deficiency
- Heme synthetase deficiency
Francesca Granata practices practicing medicine in Milan, Italy. Ms. Granata is rated as an Elite expert by MediFind in the treatment of Erythropoietic Protoporphyria. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Erythropoietic Protoporphyria, Protoporphyria, Porphyria, and Acute Intermittent Porphyria.
Gayle Ross practices practicing medicine in Melbourne, Australia. Ms. Ross is rated as an Elite expert by MediFind in the treatment of Erythropoietic Protoporphyria. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Erythropoietic Protoporphyria, Protoporphyria, Porphyria, and Porphyria Cutanea Tarda.
Bruce Wang practices practicing medicine in Taiwan. Mr. Wang is rated as an Elite expert by MediFind in the treatment of Erythropoietic Protoporphyria. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Porphyria, Acute Hepatic Porphyria (AHP), Acute Intermittent Porphyria, Erythropoietic Protoporphyria, and Liver Transplant.
Summary: The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
Summary: The purpose of this study is to collect information about the effects of EPP/XLP in adults and adolescents. This is an observational study in which participants will not receive any treatment. Study details include: * The study duration will be up to 6 months for each participant. * After Screening, participants will have a Baseline (Day 1) visit and return for visits every 4 weeks through 24 week...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center